GuideWell and Olive Debut First-Of-Its-Kind AI Solution to Accelerate Access to Health Care
GuideWell, a health solutions company and parent to the leading health insurer in Florida, and Olive, the automation company creating the Internet of Healthcare, today announced an innovative collaboration of health care and technology. Through this collaboration, GuideWell’s subsidiary, Florida Blue, becomes the first U.S. payer to automate prior authorization approvals through AI-powered clinical reviews, resulting in faster care for patients and greater provider satisfaction. This partnership will transform a frustrating, labor-intensive process, accelerating GuideWell’s mission to help people and communities achieve better health through innovation and collaboration.
“Olive’s AI platform helps GuideWell create a best-in-class utilization management model that reduces the administrative burden on our providers while creating a better experience for our members,” said Dr. Elana Schrader, Florida Blue senior vice president, healthcare services and GuideWell Health president. “By being the first health plan to automate approvals, we are leading the way for insurers to close the technology gap to better serve our members and providers.”
For most of the industry, the prior authorization process is a time-consuming endeavor for both providers and payers, requiring phone calls and faxes to provide patient medical records. Incomplete and inconsistent data can cause delays and lead to a 15-day cycle before a member receives authorization for a procedure. GuideWell’s health plan companies receive hundreds of thousands of prior authorization submissions.
By deploying Olive’s AI platform, prior authorization decision-making moves to the point of care (such as a doctor’s office). The solution will enable members to receive authorizations faster by giving providers an immediate approval from GuideWell (sometimes before a member leaves their provider’s office) when Olive’s artificial intelligence determines the prior authorization request meets GuideWell’s medical necessity requirements.
This increase in decision-making at the point of care provides patients with the right care, at the right place, at the right time. As a result, clinical staff spend less time on administrative functions and more time on patient care. Olive refers to this process — connecting the industry’s systems to more rapidly deliver intelligence that results in better human outcomes — as creating the Internet of Healthcare.
GuideWell launched a pilot with Olive in Florida last year and saw impressive results: a massive reduction in time to decision by 10 days when immediate responses were available and a 27 percent decrease in unnecessary prior authorization requests, lessening the provider’s burden and operational costs and 48 percent faster decisions leading to faster patient care.
“Olive is proud to partner with GuideWell to apply automation and AI to automatically prepare, submit and deliver payer-approved prior authorizations — one of the most broken processes in health care today,” said Jeremy Friese, MD, president, payer market at Olive. “Together, we are reimagining the care experience for patients, payers and providers.”
The companies will begin rolling out the AI platform in April, with a full-scale implementation in July for more than 2.5 million commercial members.
People In This Post
Companies In This Post
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more